Brief Information of the Cell Line and Protein
Cell Line ID: CL000014 , RAW 264.7
Synonyms
RAW264
RAW2647
RAW264.7
RAW-264.7
Raw 264.7
Raw264.7
Category Cancer cell line
Organism
Mus musculus (Mouse)
Cellosaurus ID
CVCL_0493
Protein ID: PT03589 , Toll-like receptor 7
Gene Name TLR7
Organism Mus musculus, Mouse
Protein Classification Membrane receptor
Uniprot ID P58681
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000014  Protein ID: PT03589
 
Compound ID Compound Name Compound Formula
CP0487559
4-[[4-amino-6-(2-methoxyethoxy)-2-oxo-3H-benzimidazol-1-yl]methyl]-N-[(1S,3S,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,37S,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-37,38,39,40,41,42,43,44,45,46,47,48,49-tridecahydroxy-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-36-yl]benzamide
   Show/Hide
C60H88N4O38
 1
1
EC50 = 40 nM
   TI
   LI
   LO
   TS
CP0437470
4-[[4-amino-6-(2-methoxyethoxy)-2-oxo-3H-benzimidazol-1-yl]methyl]-N-[(1S,3S,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,32S,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-32,33,34,35,36,37,38,39,40,41,42-undecahydroxy-5,10,15,20,25,30-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontan-31-yl]benzamide
   Show/Hide
C54H78N4O33
 3
1
EC50 = 57 nM
   TI
   LI
   LO
   TS
2
EC50 = 186 nM
   TI
   LI
   LO
   TS
3
EC50 = 1060 nM
   TI
   LI
   LO
   TS
CP0437469
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]benzamide
   Show/Hide
C28H38N6O14
 1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0526890
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(1S,3S,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,38R,40R,41S,42S,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-pentadecahydroxy-5,10,15,20,25,30,35,40-octakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-41-yl]benzamide
   Show/Hide
C64H96N6O43
 1
1
EC50 = 107 nM
   TI
   LI
   LO
   TS
CP0516650
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[[(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-31,32,33,34,35,36,37,38,39,40,41,42-dodecahydroxy-10,15,20,25,30-pentakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontan-5-yl]methyl]benzamide
   Show/Hide
C52H76N6O33
 1
1
EC50 = 128 nM
   TI
   LI
   LO
   TS
CP0525442
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[[(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,38R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-10,15,20,25,30,35,40-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-5-yl]methyl]benzamide
   Show/Hide
C64H96N6O43
 1
1
EC50 = 132 nM
   TI
   LI
   LO
   TS
CP0539273
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]benzamide
   Show/Hide
C28H38N6O14
 3
1
EC50 = 136 nM
   TI
   LI
   LO
   TS
2
EC50 = 277 nM
   TI
   LI
   LO
   TS
3
EC50 = 585 nM
   TI
   LI
   LO
   TS
CP0520979
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
   Show/Hide
C22H28N6O9
 1
1
EC50 = 153 nM
   TI
   LI
   LO
   TS
CP0473102
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzamide
   Show/Hide
C22H28N6O9
 3
1
EC50 = 230 nM
   TI
   LI
   LO
   TS
2
EC50 = 490 nM
   TI
   LI
   LO
   TS
3
EC50 = 909 nM
   TI
   LI
   LO
   TS
CP0487567
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]benzamide
   Show/Hide
C22H28N6O9
 1
1
EC50 = 234 nM
   TI
   LI
   LO
   TS
CP0437471
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]benzoic acid
   Show/Hide
C16H17N5O5
 3
1
EC50 = 252 nM
   TI
   LI
   LO
   TS
2
EC50 = 2110 nM
   TI
   LI
   LO
   TS
3
EC50 = 2150 nM
   TI
   LI
   LO
   TS
CP0520978
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzamide
   Show/Hide
C22H28N6O9
 1
1
EC50 = 252 nM
   TI
   LI
   LO
   TS
CP0487558
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[[(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-10,15,20,25,30,35-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methyl]benzamide
   Show/Hide
C58H86N6O38
 1
1
EC50 = 287 nM
   TI
   LI
   LO
   TS
CP0409340
4-[[6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9-yl]methyl]-N-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzamide
   Show/Hide
C22H28N6O9
 1
1
EC50 = 316 nM
   TI
   LI
   LO
   TS